ArticleRSC advances2026
Nanoparticle-based colorimetric biosensor for the detection of telomerase activity based on the peroxidase-mimicking activity of nanogold.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The early detection of cancers can be done by monitoring telomerase activity as it is considered a cancer biomarker. Several strategies for detecting telomerase have been developed, including polymerase chain reaction (PCR)-based and PCR-free assays. Despite various advantages of these strategies such as high sensitivity and accuracy, they have many limitations such as being time consuming and labor-intensive; they are also prone to provide false negatives and unsuitable for onsite testing. This study suggests a simple, fast, and low-cost method for the ultrasensitive detection of telomerase by exploiting the selective cleavage of exonuclease III and catalytic activity of nanogold. In the presence of telomerase, the primer is elongated and hybridized with its complementary strand, resulting in the formation of dsDNA with a blunt end. The dsDNA is then cleaved by exonuclease III to release the elongated primers. Once released, these primers get adsorbed on nanogold and suppress its catalytic activity. In the absence of telomerase, exonuclease III completely digests the dsDNA, resulting in the uninhibited catalytic activity of nanogold that can oxidize TMB into a blue-colored product. The proposed method enabled the detection of telomerase in 100 MCF-7 cells by the naked eye. Absorbance measurements revealed a detection limit of ∼0.3 MCF-7 cells with a wide linear range from 10
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.